What Protagonist Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 7 | 36 |
| Total trades | 17 | 82 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 283,629 | 838,741 |
| Disposed | 284,139 | 834,263 |
| Net activity | −510 | +4,478 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Ali Asif | Chief Financial Officer | Sep 30 | Open-market sale · S | −46,034 | $141.78 | −$6.53M | 59,003 |
| Ali Asif | Chief Financial Officer | Sep 30 | Open-market sale · S | −12,595 | $141.77 | −$1.79M | 105,037 |
| Ali Asif | Chief Financial Officer | Sep 30 | Exercise / conversion · M | +5,312 | $12.17 | +$64.6K | 117,632 |
| Ali Asif | Chief Financial Officer | Sep 30 | Exercise / conversion · M | +15,650 | $19.19 | +$300K | 112,320 |
| Ali Asif | Chief Financial Officer | Sep 30 | Exercise / conversion · M | +28,438 | $23.42 | +$666K | 96,670 |
| Ali Asif | Chief Financial Officer | Sep 30 | Exercise / conversion · M | +9,229 | $38.98 | +$360K | 68,232 |
| Patel Dinesh V Ph D | President and CEO | Sep 10 | Open-market sale · S | −7,278 | $144.10 | −$1.05M | 522,968 |
| Patel Dinesh V Ph D | President and CEO | Sep 10 | Exercise / conversion · M | +7,278 | $21.58 | +$157K | 530,246 |
| Patel Dinesh V Ph D | President and CEO | Sep 09 | Open-market sale · S | −63,548 | $146.18 | −$9.29M | 522,968 |
| Patel Dinesh V Ph D | President and CEO | Sep 09 | Exercise / conversion · M | +63,548 | $21.58 | +$1.37M | 586,516 |
| Patel Dinesh V Ph D | President and CEO | Sep 08 | Open-market sale · S | −54,174 | $145.87 | −$7.9M | 522,968 |
| Patel Dinesh V Ph D | President and CEO | Sep 08 | Exercise / conversion · M | +54,174 | $21.58 | +$1.17M | 577,142 |
| Patel Dinesh V Ph D | President and CEO | Sep 03 | Gift · G | −510 | — | — | 522,968 |
| Patel Dinesh V Ph D | President and CEO | Aug 11 | Open-market sale · S | −34,239 | $148.52 | −$5.09M | 523,478 |
| Patel Dinesh V Ph D | President and CEO | Aug 11 | Exercise / conversion · M | +34,239 | $21.58 | +$739K | 557,717 |
| Patel Dinesh V Ph D | President and CEO | Aug 10 | Open-market sale · S | −65,761 | $149.11 | −$9.81M | 523,478 |
| Patel Dinesh V Ph D | President and CEO | Aug 10 | Exercise / conversion · M | +65,761 | $21.58 | +$1.42M | 589,239 |
| Waddill William D. | Director | Jun 23 | Open-market sale · S | −9,000 | $117.94 | −$1.06M | 7,825 |
| Waddill William D. | Director | Jun 23 | Exercise / conversion · M | +9,000 | $16.54 | +$149K | 16,825 |
| Waddill William D. | Director | Jun 10 | Open-market sale · S | −9,000 | $107.68 | −$969K | 7,825 |
Loading...
